Comparison of Uric Acid Elevation between Aspirin-Ticagrelor and Aspirin-Prasugrel during Dual Antiplatelet Therapy: A Pilot Study
Journal of Pharmacoepidemiology and Risk Management · 2022
DOI: 10.56142/2022.14.1.51 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacoepidemiology and Risk Management, 2022. Verfasst von Seo-Won Kang und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Kang, S., Park, S., Lee, J., Lee, Y., & Min, M. (2022). Comparison of Uric Acid Elevation between Aspirin-Ticagrelor and Aspirin-Prasugrel during Dual Antiplatelet Therapy: A Pilot Study. Journal of Pharmacoepidemiology and Risk Management. https://doi.org/10.56142/2022.14.1.51
Vancouver
Kang S, Park S, Lee J, Lee Y, Min M. Comparison of Uric Acid Elevation between Aspirin-Ticagrelor and Aspirin-Prasugrel during Dual Antiplatelet Therapy: A Pilot Study. Journal of Pharmacoepidemiology and Risk Management. 2022. doi:10.56142/2022.14.1.51
BibTeX
@article{Kang2022,
author = {Kang, Seo-Won and Park, So-Jin and Lee, Jae-Hyun and Lee, Yong-Seok and Min, Myung-Sook},
title = {Comparison of Uric Acid Elevation between Aspirin-Ticagrelor and Aspirin-Prasugrel during Dual Antiplatelet Therapy: A Pilot Study},
journal = {Journal of Pharmacoepidemiology and Risk Management},
year = {2022},
doi = {10.56142/2022.14.1.51}
}
EUVIMED